[KongchangAI]
Unverified50% confidenceFactExact time

Personalized vaccines ultimately screen from hundreds or thousands of candidate mutations to select the optimal 20–34 neoantigens to encode into a single mRNA molecule.

1
Sources
50%
Confidence
Long-term
Relevance
9/7/2026
First Seen

Sources

Moderna's Personalized Cancer Vaccine Succeeds in Phase 3 Trial, Stock Surges 110%

Related Entities

mRNA-4157/V940product新抗原concept

Related Claims

UnverifiedSimoa (Single Molecule Array) technology, developed by Quanterix, can improve the detection sensitivity of traditional ELISA by approximately 1000-fold.58% similar

Cite This Claim

Stable URI
https://kongchang.com/claim/873267
API
curl https://kongchang.com/api/v1/knowledge/claims/873267
MCP
get_claim(id=873267)